401 related articles for article (PubMed ID: 16805778)
1. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
Masters CL; Cappai R; Barnham KJ; Villemagne VL
J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
[TBL] [Abstract][Full Text] [Related]
2. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.
Villemagne VL; Rowe CC; Macfarlane S; Novakovic KE; Masters CL
J Clin Neurosci; 2005 Apr; 12(3):221-30. PubMed ID: 15851069
[TBL] [Abstract][Full Text] [Related]
3. La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.
Villemagne VL; Ng S; Cappai R; Barnham KJ; Fodero-Tavoletti MT; Rowe CC; Masters CL
Neuroradiol J; 2006 Oct; 19(4):453-74. PubMed ID: 24351248
[TBL] [Abstract][Full Text] [Related]
4. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-beta aggregation.
Finder VH; Glockshuber R
Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
[TBL] [Abstract][Full Text] [Related]
6. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
7. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease?
Nichols L; Pike VW; Cai L; Innis RB
Biol Psychiatry; 2006 May; 59(10):940-7. PubMed ID: 16487944
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
9. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
10. Regression stage senile plaques in the natural course of Alzheimer's disease.
Oide T; Kinoshita T; Arima K
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
12. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
[TBL] [Abstract][Full Text] [Related]
13. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.
Bates KA; Verdile G; Li QX; Ames D; Hudson P; Masters CL; Martins RN
Mol Psychiatry; 2009 May; 14(5):469-86. PubMed ID: 18794889
[TBL] [Abstract][Full Text] [Related]
14. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.
Nicoll JA; Yamada M; Frackowiak J; Mazur-Kolecka B; Weller RO
Neurobiol Aging; 2004; 25(5):589-97; discussion 603-4. PubMed ID: 15172734
[TBL] [Abstract][Full Text] [Related]
15. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive characterization of beta-amyloid(1-40) vasoactivity by functional magnetic resonance imaging in mice.
Luo F; Seifert TR; Edalji R; Loebbert RW; Hradil VP; Harlan J; Schmidt M; Nimmrich V; Cox BF; Fox GB
Neuroscience; 2008 Jul; 155(1):263-9. PubMed ID: 18534764
[TBL] [Abstract][Full Text] [Related]
18. The development of amyloid beta protein deposits in the aged brain.
Thal DR; Capetillo-Zarate E; Del Tredici K; Braak H
Sci Aging Knowledge Environ; 2006 Mar; 2006(6):re1. PubMed ID: 16525193
[TBL] [Abstract][Full Text] [Related]
19. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
MacDonald AB
Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
